Skip to content

Clinical trials

Phase 3 Respiratory Distress Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Phase 3 Country / region: United States Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20031
20051
20061
20072
20082
20092
20101
20111
20161
20172
20207
20212
20222
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated15
Recruiting5
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NICHD Neonatal Research Network7
National Heart, Lung, and Blood Institute (NHLBI)3
Massachusetts General Hospital2
ONY2
University of Minnesota2
Adrian Hernandez1
Aerogen Pharma Limited1
Alexion Pharmaceuticals, Inc.1
AstraZeneca1
Beth Israel Deaconess Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome36
Premature Birth10
Respiratory Insufficiency7
COVID-196
Acute Lung Injury5
Bronchopulmonary Dysplasia4
Coronavirus Infections4
Lung Diseases4
Pneumonia4
Severe Acute Respiratory Syndrome4

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.